[go: up one dir, main page]

SG11201708142XA - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
SG11201708142XA
SG11201708142XA SG11201708142XA SG11201708142XA SG11201708142XA SG 11201708142X A SG11201708142X A SG 11201708142XA SG 11201708142X A SG11201708142X A SG 11201708142XA SG 11201708142X A SG11201708142X A SG 11201708142XA SG 11201708142X A SG11201708142X A SG 11201708142XA
Authority
SG
Singapore
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
SG11201708142XA
Other languages
English (en)
Inventor
Chaitanya Dutt
Jaya Abraham
Vivek Mishra
Amit Kesarwani
Ramesh Chandra Gupta
Shailesh Deshpande
Shital Kumar Zambad
Anoop Mathur
Jignesh Kotecha
Sachin Latad
Manish Patel
Anita Chaudhari
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of SG11201708142XA publication Critical patent/SG11201708142XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201708142XA 2015-04-08 2016-04-05 Pharmaceutical formulations SG11201708142XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1475MU2015 2015-04-08
PCT/IB2016/051920 WO2016162787A1 (en) 2015-04-08 2016-04-05 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
SG11201708142XA true SG11201708142XA (en) 2017-11-29

Family

ID=55808800

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201708142XA SG11201708142XA (en) 2015-04-08 2016-04-05 Pharmaceutical formulations

Country Status (31)

Country Link
US (1) US10772879B2 (he)
EP (1) EP3280447B1 (he)
JP (1) JP6736656B2 (he)
KR (1) KR20170134662A (he)
CN (1) CN107530287B (he)
AR (1) AR104185A1 (he)
AU (1) AU2016246124B2 (he)
BR (1) BR112017021669A2 (he)
CA (1) CA2997463A1 (he)
CY (1) CY1121921T1 (he)
DK (1) DK3280447T3 (he)
EA (1) EA037041B1 (he)
ES (1) ES2724629T3 (he)
HR (1) HRP20190783T1 (he)
HU (1) HUE044889T2 (he)
IL (1) IL254794B (he)
LT (1) LT3280447T (he)
MX (1) MX387639B (he)
MY (1) MY182008A (he)
PH (1) PH12017501829A1 (he)
PL (1) PL3280447T3 (he)
PT (1) PT3280447T (he)
RS (1) RS58708B1 (he)
SG (1) SG11201708142XA (he)
SI (1) SI3280447T1 (he)
SM (1) SMT201900264T1 (he)
TR (1) TR201906476T4 (he)
TW (1) TWI713512B (he)
UA (1) UA123051C2 (he)
WO (1) WO2016162787A1 (he)
ZA (1) ZA201707094B (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007972A2 (en) 2012-06-15 2014-01-09 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinphrine
PT2976072T (pt) 2013-03-22 2021-08-12 Univ Nova Southeastern Partículas finas de epinefrina e métodos de utilização das mesmas para o tratamento de afeções que reagem à epinefrina
US12357591B2 (en) 2018-10-19 2025-07-15 Nova Southeastern University Sublingual epinephrine compositions including pH-modifying excipients and penetration enhancers and methods for use thereof
SG11202110315SA (en) 2019-04-03 2021-10-28 Astellas Pharma Inc Pharmaceutical composition
KR102330597B1 (ko) * 2020-04-17 2021-11-26 보령제약 주식회사 무정형의 엠파글리플로진을 포함하는 안정성이 향상된 신규 약제학적 제형

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2301477T3 (es) * 1999-02-22 2008-07-01 Merrion Research I Limited Forma de dosificacion oral solida que contiene un potenciador.
DE69915143T2 (de) 1999-10-06 2004-10-14 Torrent Pharmaceuticals Ltd., Ahmedabad Pyridinium-derivate zur behandlung von altersbedingten und diabetischen vaskulären komplikationen, verfahren zu ihrer herstellung und ihre pharmazeutischen anwendungen
ATE299496T1 (de) 2001-03-21 2005-07-15 Torrent Pharmaceuticals Ltd Pyridiniumverbindungen zur behandlung von age- relatierten krankheiten
MX2008011227A (es) 2006-03-03 2009-02-10 Torrent Pharmaceuticals Ltd Receptores antagonistas de accion nueva y doble en los receptores at1 y eta.
JP2009023932A (ja) * 2007-07-18 2009-02-05 Tama Tlo Kk N−メチルピリジニウム化合物を有効成分として含有する抗ウイルス剤、それを含有する、抗ウイルス組成物、食餌及び動物用飼料
EP2254563A2 (en) * 2008-01-25 2010-12-01 Torrent Pharmaceuticals Ltd. Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
CN101574343B (zh) * 2008-05-07 2011-06-01 吉林大学 一种治疗糖尿病的药物组合物
EA201171368A1 (ru) * 2009-05-07 2012-04-30 Торрент Фармасьютикалз Лимитед Новые гетероциклические соединения
EP2512454A2 (en) * 2009-12-16 2012-10-24 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
CN104069066B (zh) * 2013-03-25 2017-04-19 吉林大学 黄癸固体分散体及其在治疗糖尿病及并发症中的应用

Also Published As

Publication number Publication date
LT3280447T (lt) 2019-05-27
US20180110763A1 (en) 2018-04-26
SMT201900264T1 (it) 2019-07-11
KR20170134662A (ko) 2017-12-06
AU2016246124A1 (en) 2017-11-02
WO2016162787A1 (en) 2016-10-13
ES2724629T3 (es) 2019-09-12
IL254794B (he) 2021-05-31
TW201642858A (zh) 2016-12-16
CN107530287A (zh) 2018-01-02
AR104185A1 (es) 2017-07-05
HRP20190783T1 (hr) 2019-06-28
MY182008A (en) 2021-01-18
JP6736656B2 (ja) 2020-08-05
ZA201707094B (en) 2021-04-28
HUE044889T2 (hu) 2019-11-28
EA037041B1 (ru) 2021-01-29
PT3280447T (pt) 2019-05-14
MX387639B (es) 2025-03-18
JP2018510916A (ja) 2018-04-19
UA123051C2 (uk) 2021-02-10
PH12017501829A1 (en) 2018-04-23
SI3280447T1 (sl) 2019-06-28
EA201792237A1 (ru) 2018-02-28
TWI713512B (zh) 2020-12-21
MX2017012942A (es) 2018-01-30
BR112017021669A2 (pt) 2018-07-10
CA2997463A1 (en) 2016-10-13
IL254794A0 (he) 2017-12-31
CY1121921T1 (el) 2020-10-14
EP3280447A1 (en) 2018-02-14
DK3280447T3 (da) 2019-05-13
EP3280447B1 (en) 2019-02-27
CN107530287B (zh) 2020-11-10
TR201906476T4 (tr) 2019-05-21
RS58708B1 (sr) 2019-06-28
US10772879B2 (en) 2020-09-15
AU2016246124B2 (en) 2019-11-14
PL3280447T3 (pl) 2019-07-31

Similar Documents

Publication Publication Date Title
IL246978A0 (he) פורמולציות פרמבצבטיות חדשות
PL4233846T3 (pl) Formulacje farmaceutyczne
ZA201903101B (en) Pharmaceutical formulations
IL256491A (he) תכשירי רוקחות
PT3426294T (pt) Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina
IL262745A (he) תכשירים משופרים המכילים תרופות
IL253177B (he) תכשיר רוקחות
IL266537A (he) תכשיר רוקחי
IL253570B (he) הרכב רוקחות
EP3383371C0 (en) PHARMACEUTICAL FORMULATION
ZA201707094B (en) Pharmaceutical formulations
GB201521462D0 (en) Pharmaceutical composition
IL263167A (he) תכשיר רוקחות
EP3337463A4 (en) PHARMACEUTICAL FORMULATIONS
GB201515310D0 (en) Pharmaceutical composition
IL255510A (he) תכשירים רוקחיים
GB201520862D0 (en) Pharmaceutical composition
GB201506755D0 (en) Novel pharmaceutical formulation
GB201511246D0 (en) Pharmaceutical formulation
IL271908A (he) תכשירים פרמצבטיים הדחוסות-יתר
GB201417589D0 (en) Pharmaceutical Formulations
HK40097404A (en) Pharmaceutical formulations
GB201610440D0 (en) Pharmaceutical formulations
PT3319596T (pt) Composições farmacêuticas
GB201521456D0 (en) Pharmaceutical composition